Efficacy and Safety of Lanabecestat for Treatment of Early and Mild Alzheimer Disease

JAMA Neurology Author Interviews - Un pódcast de JAMA Network - Lunes

prueba podimo gratis durante 60 días!

Miles de audiolibros y podcasts exclusivos, haz clic aquí para probar

Interview with John Sims, author of Efficacy and Safety of Lanabecestat for Treatment of Early and Mild Alzheimer Disease: The AMARANTH and DAYBREAK-ALZ Randomized Clinical Trials

Visit the podcast's native language site